Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$268.66-0.47 (-0.17%)
Delayed quote: Sep 9, 2026, 2:05 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 2:05 PM EDT
Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly operating cash flow is $4.71B with a quarterly period change of +87.39%. Operating cash flow is the cash generated by core business operations before capital expenditures.
Reported quarterly operating cash flow; no daily interpolation.
Operating Cash Flow growth vs the same quarter one year earlier, last 40 quarters.
| Period | Operating Cash Flow | % Change |
|---|---|---|
| Quarter ended Jun 2026 | $4.71B | +87.39% |
| Quarter ended Mar 2026 | $2.51B | (65.60%) |
| Quarter ended Dec 2025 | $7.31B | (20.29%) |
| Quarter ended Sep 2025 | $9.17B | +136.44% |
| Quarter ended Jun 2025 | $3.88B | (7.09%) |
| Quarter ended Mar 2025 | $4.17B | (40.23%) |
| Quarter ended Dec 2024 | $6.98B | (12.64%) |
| Quarter ended Sep 2024 | $7.99B | +41.90% |
| Quarter ended Jun 2024 | $5.63B | +54.03% |
| Quarter ended Mar 2024 | $3.66B | (53.49%) |
| Quarter ended Dec 2023 | $7.86B | +4.99% |
| Quarter ended Oct 2023 | $7.49B | +79.08% |
| Quarter ended Jul 2023 | $4.18B | +28.40% |
| Quarter ended Apr 2023 | $3.26B | (39.12%) |
| Quarter ended Dec 2022 | $5.35B | (14.86%) |
| Quarter ended Oct 2022 | $6.28B | +12.60% |
| Quarter ended Jul 2022 | $5.58B | +40.26% |
| Quarter ended Apr 2022 | $3.98B | (30.58%) |
| Quarter ended Dec 2021 | $5.73B | (30.86%) |
| Quarter ended Oct 2021 | $8.29B | +56.00% |
| Quarter ended Jul 2021 | $5.31B | +30.44% |
| Quarter ended Apr 2021 | $4.07B | (51.17%) |
| Quarter ended Dec 2020 | $8.34B | (0.48%) |
| Quarter ended Sep 2020 | $8.38B | +142.84% |
| Quarter ended Jun 2020 | $3.45B | +2.80% |
| Quarter ended Mar 2020 | $3.36B | (47.51%) |
| Quarter ended Dec 2019 | $6.40B | (15.00%) |
| Quarter ended Sep 2019 | $7.53B | +26.55% |
| Quarter ended Jun 2019 | $5.95B | +67.88% |
| Quarter ended Mar 2019 | $3.54B | (43.26%) |
| Quarter ended Dec 2018 | $6.24B | (0.45%) |
| Quarter ended Sep 2018 | $6.27B | +3.17% |
| Quarter ended Jul 2018 | $6.08B | +68.58% |
| Quarter ended Apr 2018 | $3.61B | (40.93%) |
| Quarter ended Dec 2017 | $6.11B | (2.57%) |
| Quarter ended Oct 2017 | $6.27B | +8.56% |
| Quarter ended Jul 2017 | $5.77B | +98.15% |
| Quarter ended Apr 2017 | $2.91B | (56.22%) |
| Quarter ended Dec 2016 | $6.65B | +24.10% |
| Quarter ended Oct 2016 | $5.36B | +7.43% |
| Quarter ended Jul 2016 | $4.99B | +183.04% |
| Quarter ended Apr 2016 | $1.76B | (65.31%) |
| Quarter ended Dec 2015 | $5.08B | (17.03%) |
| Quarter ended Sep 2015 | $6.13B | +17.79% |
| Quarter ended Jun 2015 | $5.20B | +81.06% |
| Quarter ended Mar 2015 | $2.87B | (34.20%) |
| Quarter ended Dec 2014 | $4.37B | (6.21%) |
| Quarter ended Sep 2014 | $4.65B | (15.83%) |
| Quarter ended Jun 2014 | $5.53B | +40.94% |
| Quarter ended Mar 2014 | $3.92B | (5.22%) |
| Quarter ended Dec 2013 | $4.14B | (30.40%) |
| Quarter ended Sep 2013 | $5.95B | +17.74% |
| Quarter ended Jun 2013 | $5.05B | +121.83% |
| Quarter ended Mar 2013 | $2.28B | (32.55%) |
| Quarter ended Dec 2012 | $3.38B | (24.93%) |
| Quarter ended Sep 2012 | $4.50B | (4.89%) |
| Quarter ended Jul 2012 | $4.73B | +69.16% |
| Quarter ended Apr 2012 | $2.79B | (19.01%) |
| Quarter ended Dec 2011 | $3.45B | (25.34%) |
| Quarter ended Oct 2011 | $4.62B | +18.24% |
| Quarter ended Jul 2011 | $3.91B | +68.78% |
| Quarter ended Apr 2011 | $2.32B | (39.44%) |
| Quarter ended Dec 2010 | $3.82B | (24.04%) |
| Quarter ended Oct 2010 | $5.03B | +31.20% |
| Quarter ended Jul 2010 | $3.84B | +3.98% |
| Quarter ended Apr 2010 | $3.69B | (30.21%) |
| Quarter ended Dec 2009 | $5.29B | +3.79% |
| Quarter ended Sep 2009 | $5.09B | +51.47% |
| Quarter ended Jun 2009 | $3.36B | +18.96% |
| Quarter ended Mar 2009 | $2.83B | (29.34%) |
| Quarter ended Dec 2008 | $4.00B | (18.23%) |
| Quarter ended Sep 2008 | $4.89B | +72.17% |
| Quarter ended Jun 2008 | $2.84B | (12.18%) |
| Quarter ended Mar 2008 | $3.24B | (25.16%) |
| Quarter ended Dec 2007 | $4.32B | +3.17% |
| Quarter ended Sep 2007 | $4.19B | +44.67% |
| Quarter ended Jul 2007 | $2.90B | (24.50%) |
| Quarter ended Apr 2007 | $3.84B | (10.41%) |
| Quarter ended Dec 2006 | $4.28B | +3.58% |
| Quarter ended Oct 2006 | $4.13B | +75.51% |
| Quarter ended Jul 2006 | $2.36B | (32.18%) |
| Quarter ended Apr 2006 | $3.47B | +9.14% |
| Quarter ended Dec 2005 | $3.18B | (20.56%) |
| Quarter ended Oct 2005 | $4.01B | +97.10% |
| Quarter ended Jul 2005 | $2.03B | (23.40%) |
| Quarter ended Apr 2005 | $2.65B | +7.84% |
| Quarter ended Dec 2004 | $2.46B | (36.72%) |
| Quarter ended Sep 2004 | $3.89B | +82.93% |
| Quarter ended Jun 2004 | $2.13B | (19.92%) |
| Quarter ended Mar 2004 | $2.65B | (25.25%) |
| Quarter ended Dec 2003 | $3.55B | +6.03% |
| Quarter ended Sep 2003 | $3.35B | +102.17% |
| Quarter ended Jun 2003 | $1.66B | (18.61%) |
| Quarter ended Mar 2003 | $2.04B | (4.28%) |
| Quarter ended Dec 2002 | $2.13B | (16.78%) |
| Quarter ended Sep 2002 | $2.56B | N/A |